Medtronic Invests $100M in Pulnovo Medical for AI Innovation

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in AI within the healthcare and life sciences sectors. This week, we highlight the expanded partnership between Cepheid and Oxford Nanopore Technologies, which aims to enhance AI-driven genomic workflows for infectious disease research. Additionally, Ryght AI has launched RyghtSites.com, a free platform designed to streamline the selection of clinical trial sites, potentially reducing time and costs for drug developers.

In other news, OpenAI has introduced GPT-Rosalind, a new AI model set to advance research in biology and drug discovery. Meanwhile, Pulnovo Medical has received a significant investment from Medtronic to further develop AI-driven therapies for pulmonary conditions. These stories, along with many others, showcase the dynamic intersection of AI and healthcare, promising to transform patient care and medical research.

Cepheid and Oxford Nanopore Expand Partnership for Genomic Workflows

Cepheid and Oxford Nanopore Technologies have announced an expansion of their partnership to develop a workflow for rapid identification of bacterial and fungal pathogens, enhancing AI-driven genomic workflows for infectious disease research. Read more

EmpiRx Health Launches AI Infusion Therapy Solution

EmpiRx Health has launched an AI-powered Infusion Therapy Management solution to reduce costs and improve care by transitioning therapies from medical to pharmacy benefits. Read more

Ryght AI Launches Free AI Tool for Clinical Trial Site Selection

On April 16, 2026, Ryght AI introduced RyghtSites.com, a free AI-powered platform designed to assist drug developers and CROs in selecting clinical trial sites from a global database. Read more

OpenAI Launches GPT-Rosalind for Life Sciences

OpenAI has introduced GPT-Rosalind, a new AI model aimed at advancing research in biology, drug discovery, and translational medicine. The model is designed to improve scientific workflows and is available to qualified customers with a Life Sciences research plugin for Codex. Read more

Bracco Imaging and NYU Langone Health Form AI Alliance

Bracco Imaging and NYU Langone Health have announced a multi-year strategic alliance to enhance AI in medical imaging. The partnership will focus on advancing MRI, CT, Ultrasound, and AI-enabled PET/CT and MRI image analysis to improve diagnostics and clinical decision-making. Read more

Mitate Zepto Technica Joins JST Edge AI Program

Mitate Zepto Technica has joined the Japan Science and Technology Agency's Edge AI Semiconductor R&D Program. The company aims to commercialize its genome-analysis accelerator, RASEN, by integrating AI research for improved genomic computation. Read more

Nanostics Validates AI Models for Prostate Cancer Prediction

Nanostics Inc. has validated its AI-driven ClarityDX Prostate models, which enhance the prediction of aggressive prostate cancer, potentially reducing unnecessary biopsies by 47%. Read more

Pulnovo Medical Receives $100M Investment from Medtronic

Pulnovo Medical has secured a $100 million investment from Medtronic to further develop AI-driven therapies for pulmonary hypertension and heart failure. This funding will aid in expanding their market reach and pursuing FDA approval. Read more

Oracle Health Achieves CMS Aligned Network Status

Oracle Health has been recognized as a CMS Aligned Network, focusing on improving patient access to healthcare data through AI-enabled interoperability solutions. Read more

Boehringer Ingelheim Opens AI Centre in London

German pharmaceutical company Boehringer Ingelheim has opened an AI and machine learning centre in London to boost its drug research and development capabilities, with a planned investment of £150 million over the next decade. Read more

Sectra Secures £15.6 Million NHS Contract

International medical imaging IT company Sectra has signed a contract to provide cloud imaging services to six NHS Trusts in London, aiming to enhance cybersecurity and patient care. Read more

Biossil Uses AI to Revive Failed Drugs

Toronto-based startup Biossil, supported by Peter Thiel and OpenAI, is using AI to repurpose drug candidates that failed in human trials. The company is working with multiple universities and research hospitals to seek approval for repurposed drugs. Read more

MyOme Appoints New Board Members

MyOme has appointed Sam Roosz and Dr. Ravi Thadhani to its Board of Directors to enhance its AI-powered genomics strategy. Read more

Accuity Wins 2026 AI Excellence Award in Healthcare

Accuity has been recognized with the 2026 Artificial Intelligence Excellence Award for its responsible AI innovations in healthcare, particularly through its AI engine, Amplifi. Read more

Brado AI Enhances Healthcare Interoperability

Brado AI has completed the CMS Health Technology Ecosystem pledge to improve interoperability and patient access to health information, using conversational AI assistants for secure data access. Read more

Castle Biosciences to Present AI Insights on Melanoma Risk

Castle Biosciences will present new data on its AI-driven DecisionDx-Melanoma test at the EADO and ACMS meetings, showcasing its ability to enhance risk assessment for early-stage melanoma patients. Read more

OpenProtein.AI Introduces No-Code Protein Design Tools

OpenProtein.AI has launched new no-code tools for protein design, allowing biologists to engineer proteins and predict their structures without coding expertise. This initiative aims to speed up drug development and improve biological system understanding. Read more

GRAIL to Present New Data on AI-Driven Cancer Detection at ASCO 2026

GRAIL, Inc. will present new findings from the NHS-Galleri trial and PATHFINDER 2 study at the 2026 ASCO Annual Meeting, focusing on the Galleri multi-cancer early detection test. These studies involve over 142,000 and 32,000 participants respectively, aiming to demonstrate the effectiveness of early cancer detection. Read more

Catalight and Cognoa Partner for AI Autism Diagnosis

The nonprofit Catalight Group has teamed up with Cognoa to enhance early autism diagnosis using AI technology. This partnership aims to expedite the diagnostic process and connect families to care, utilizing Cognoa's FDA-authorized tool, Canvas Dx™. Read more

Coral Secures $12.5M for Healthcare Automation

Coral, a startup automating healthcare administrative tasks, has raised $12.5 million to enhance its technology and expand services. Read more

Immunofoco's AI-Enhanced CAR-T Therapy Shows Promise

Immunofoco has presented preclinical data for its AI-enhanced CAR-T therapy, IMV102, at the AACR 2026. The therapy demonstrated significant anti-tumor activity in multiple myeloma models, showcasing advancements over traditional CAR-T therapies. Read more

BayCare and Rovex Test Robotics for Patient Transport

BayCare Health System and Rovex have initiated a pilot program at Morton Plant Hospital to explore the use of robotic technology in improving hospital operations and patient transport workflows. Read more

WCG Acquires The Contract Network for AI in Clinical Research

On April 21, 2026, WCG announced its acquisition of The Contract Network to enhance its AI-driven capabilities in clinical research. This move aims to integrate contract intelligence into WCG's ClinSphere® platform, improving decision-making and workflows in clinical trials. Read more

VytlOne Launches VytlAIQ AI Platform

On April 21, 2026, VytlOne announced the launch of VytlAIQ, an AI platform aimed at improving pharmacy services and 340B program performance through data unification and predictive intelligence. Read more

Rad AI Study: Domain-Specific Models Excel in Radiology

A study published in npj Digital Medicine indicates that domain-specific AI models are favored by radiologists over general-purpose models for radiology impressions, as they produce higher quality results. Read more

CerraCap Ventures Invests in Nephronomics for AI Kidney Innovations

CerraCap Ventures has invested in Nephronomics, a company using AI to develop precision therapies for kidney disease. This investment aims to enhance healthcare systems and speed up drug development for chronic kidney disease. Read more

Insilico Medicine Forms Longevity Board for AI Aging Research

Insilico Medicine has launched the first Longevity Board to guide AI-driven aging research and drug discovery, aiming to develop therapeutics targeting aging processes. Read more

MasterControl Introduces AI Event Summarizer

MasterControl has launched an AI-powered Event Summarizer to improve quality management in the life sciences sector by generating concise summaries of complex quality events. Read more

PrecisionLife and Ovation Partner on AI-Driven GLP-1 Tests

PrecisionLife and Ovation are collaborating to commercialize AI-driven GLP-1 stratification tests and a consumer DNA test to improve patient outcomes for GLP-1 therapies. Read more

Texas Biomedical Research Institute Uses AI for Drug Development

The Texas Biomedical Research Institute is utilizing AI and advanced tools to develop new methodologies for drug development, focusing on enhancing safety and efficacy studies. Read more

Wobble Genomics Unveils mRNA Sequencing Research at AACR 2026

Wobble Genomics is set to present new findings on full-length mRNA sequencing from blood, aimed at enhancing antibody-drug conjugate therapy selection for breast cancer, at the AACR Annual Meeting 2026. The research underscores the potential of liquid biopsies in non-invasive treatment selection for precision oncology. Read more

Viva Biotech Integrates AI in Drug Discovery

In a recent webinar, Viva Biotech explored the use of AI and flow chemistry to enhance scalable drug discovery processes. Read more

Categories

Companies

Resources

Medtronic Invests $100M in Pulnovo Medical for AI Innovation - Life AI Weekly #64

We hope you enjoyed this article.

More from: Life Sciences

Subscribe to Life AI Weekly